We are thrilled to be one of two companies selected as presenters at the NewYorkBIO Annual Holiday Reception! Come see us present at the New York Stock Exchange on December 9th: NewYorkBIO's Holiday Reception: https://lnkd.in/eAkpv-uM #AI #DrugDiscovery #TechBio #NewYork
About us
Serinus Biosciences is redefining precision in cancer therapeutics. We design models to determine how molecules function inside each tumor cell. Through our knowledge-primed AI engine, we integrate computational biology and functional genomics to uncover the molecular landscape of treatment response or resistance. Our technology enables development of drugs that work across a wide range of patient populations, override resistance mechanisms, and enable combinations by design.
- Website
-
https://www.serinus.bio
External link for Serinus Biosciences
- Industry
- Biotechnology Research
- Company size
- 2-10 employees
- Type
- Privately Held
- Founded
- 2022
- Specialties
- Precision medicine, Cancer biology, AI/ML, Computational biology, and Drug development